RECRUITING

Intracranial Stimulation Mapping In Epilepsy

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a single group prospective study to determine the feasibility for generating brain maps that localize cerebral functions and inter-regional information flow in partial epilepsy in adult patients.

Official Title

Intracranial Stimulation Mapping In Epilepsy -The InStim Study

Quick Facts

Study Start:2022-06-01
Study Completion:2026-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05290610

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male or female 18 years and older at screening.
  2. * Written informed consent is obtained from the participant to comply with the requirements of the study.
  3. * Stated willingness to comply with all study procedures and availability for the duration of the study
  4. * Currently undergoing clinically indicated intracranial EEG monitoring for planning of epilepsy surgery in the University of Minnesota/MINCEP program.
  1. * Pregnancy ruled out prior to approval for intracranial EG monitoring.
  2. * Persons who are rendered temporarily or permanently invulnerable by inability to understand the research due to study complexity, cognitive impairment, or by inability to make independent decisions owing to University of Minnesota or to Fairview health services.

Contacts and Locations

Study Contact

Matthew Maple
CONTACT
612-946-1424
maple036@umn.edu

Principal Investigator

Alexander Herman, MD
PRINCIPAL_INVESTIGATOR
UMN

Study Locations (Sites)

University of Minnesota
Minneapolis, Minnesota, 55455
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Alexander Herman, MD, PRINCIPAL_INVESTIGATOR, UMN

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-06-01
Study Completion Date2026-09-01

Study Record Updates

Study Start Date2022-06-01
Study Completion Date2026-09-01

Terms related to this study

Additional Relevant MeSH Terms

  • Epilepsy